| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 |
| filingDate |
2012-09-25^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1f8a8f2272f00f1d2deebc22130765d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a089f20bcb579f8b5fdb3a966d33933
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aca477cdf67f329f01a683674c8d31c2 |
| publicationDate |
2013-04-11^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013090334-A1 |
| titleOfInvention |
Azabenzoxazine derivatives as crac modulators |
| abstract |
Compounds of the formula (I): n n n n n n n n n n or pharmaceutically acceptable salts thereof, wherein R 1 and R 2 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with calcium release-activated calcium channels (CRAC). |
| priorityDate |
2011-10-05^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |